Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways-Reference-Cited by-同舟云学术

Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways

Published:2015-08-06 Issue:10 Volume:107 Page:djv212
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI.J

Author:

Johnston Stephen R. D.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/107/10/djv212/7678718/djv212.pdf

Reference60 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

2. Mechanisms of tamoxifen resistance

3. Endocrine-responsive breast cancer and strategies for combating resistance

4. Estrogen-Receptor Biology: Continuing Progress and Therapeutic Implications

5. Network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Breast Cancer. Version 3.2014. NCCN Guidelines for Patients available at www.NCCN.org/patients. 2014.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MEDICATION-RELATED OSTEONECROSIS OF THE JAW: A REVIEW STUDY;Revista Contemporânea;2024-06-28

2. Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer;Journal of Oncology Pharmacy Practice;2024-02-25

3. Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation;Oncology Research;2024

4. ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer;eLife;2023-09-29

5. The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis;International Journal of Molecular Sciences;2023-06-22